To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
Clinical trial NCT02093351 · COMPLETED
Trial details
- NCT number
- NCT02093351
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-04-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.